FDA issues safety risk for HIV drug FDA approves expanded use of breast cancer drug FDA tentatively approves bone cancer generic URAC gears up for Best Practices Awards FDA approves labeling update for HIV drug AmerisourceBergen sees earnings surge across the board Bayer to halt phase 2 trial of hemophilia treatment BioScrip to acquire Critical Homecare Solutions Acorda appoints EVP commercial development FDA approves Ampyra First Previous 213 214 215 216 217 Next Last
